NCT06918834: Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients
- State
- Under way
- Phase
- Phase 2
- People
- 236 planned
- Started
- 24 Jul 2025
- Primary completion
- 1 Apr 2028
- Arms
- Immediate HSCT Group
- Results
- None posted
- 9 Apr 2025: Trial registered
- 24 Jul 2025: Trial started